囊性纤维化肺移植中的代谢并发症 - 一项病例对照研究
Grace Y Lam1,2, Hima Patel1, Heather Sharpe1
1Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, Edmonton, Alberta, Canada.
Heliyon
|May 6, 2024
概括
患有囊性纤维化 (CF) 的患者在肺移植后患上新发糖尿病的风险显著增加. 在CF患者和非CF患者之间,代谢并发症的发生率相似,这强调了CF患者需要密切监测的必要性.
科学领域:
- 移植免疫学 移植免疫学
- 肺部医学 肺部医学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 肺移植后的代谢并发症尚未得到充分了解.
- 患有囊性纤维化 (pwCF) 和没有囊性纤维化 (pwoCF) 患者的移植后结果的差异尚不清楚.
研究的目的:
- 为了比较pwCF和 pwoCF之间的肺移植后结果.
- 为了研究存活率和糖尿病,血脂不良,高血压和功能障碍的发生率的差异.
主要方法:
- 在90 pwCF和90 pwoCF的回顾性病例控制研究 (2004-2017) 中.
- 根据年龄,性别和移植年份进行匹配.
- 分析包括人口,代谢和药物数据;生存分析使用卡普兰-梅尔和日志等级测试;后勤回归确定了独立的风险因素.
主要成果:
- PwCF年轻,体重指数较低,移植前ECMO使用较少.
- 在pwCF和 pwoCF之间,整体存活率没有显著差异.
- CF状态与移植后新发糖尿病风险显著增加有关 (aOR 28.7).
结论:
- 在肺移植后,PwCF面临的新发糖尿病的调整风险要高得多.
- 除此之外,pwCF和 pwoCF之间的代谢并发症率是相似的.
- 严格监测代谢并发症对于pwCF后肺移植至关重要.
相关概念视频
Cystic Fibrosis: Management
155
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
155
Cystic Fibrosis: Pathogenesis
222
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
222
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


